glp 1 and gip agonist Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research The Effects of Dual GLP-1/GIP
Description
What happens in your body after the first GLP-1 dose The moment a GLP-1 receptor agonist enters your bloodstream, a cascade begins

Looking for more diabetes videos

Birth of the incretin concept The same year Lim and Kosaka published their hypothesis, the Belgian physiologist La Barre attempted to purify secretin with Eugene Still, a colleague at the University of Chicago

Compromised autophagy and neurodegenerative diseases

The incretin agonist I-M-150846 revealed a complete loss of function at GLP-1R while retaining GIPR activity (Table 1)

Some studies report an increase in insulin dose in patient populations on oral diabetic agents, although this was found in the context of strict insulin titration afterwards
